PT - JOURNAL ARTICLE AU - Francisco Novillo AU - Shuheng Lai AU - Geovanna Cárdenas AU - Francisca Verdugo AU - Gabriel Rada TI - Periodontal therapy on disease activity of Rheumatoid Arthritis. Systematic review and meta-analysis AID - 10.1101/2020.05.25.20111328 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.25.20111328 4099 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20111328.short 4100 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20111328.full AB - Objective The objective of this systematic review is to assess the impact of periodontal therapy on disease activity of patients with Rheumatoid ArthritisData Sources We will conduct a comprehensive search in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH) and grey literature, to identify all relevant randomized controlled trials regardless of language or publication status (published, unpublished, in press and in progress).Elegibility Criteria for Selecting Studies and Methods We will include randomised trials evaluating the effect of periodontal therapy on disease activity of rheumatoid arthritis. Two reviewers will independently screen each study for eligibility, data extraction, and assess the risk of bias. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome.Ethics and Dissemination No ethics approval is considered necessary. The results of this review will be disseminated via peer-reviewed publications, social networks and traditional media.PROSPERO Registration ID CRD42020150286.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was not commissioned by any organisation and did not receive external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As researchers will not access information that could lead to the identification of individual participants, obtaining ethical approval was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data related to the project will be available on the final publication.